<p>James Larkin joins to discuss adjuvant durva/treme vs observation in high risk resected RCC</p>

Episode 448: Neoadjuvant EV/Pembro in Cis-ineligible MIBC

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London